# Trade Mark Journal No.2026/013 27 March 2026

## WO0000001906758 (5,42)

Office of origin: United States of America

Date of International Registration:23 December 2025
Date of designation in the UK: 23 December 2025

A circle made up of dots of varying sizes with a lower case "n" in the middle.

International priority date claimed: 30 July 2025 (United States of America) (99311321)
International priority date claimed: 30 July 2025 (United States of America) (99311327)

Class 5
  Pharmaceutical preparations for the treatment of infectious diseases; vaccines; adjuvants for medical purposes.
Class 42
  Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, vaccines, and clinical trials and post-market trials related to pharmaceuticals, biologics, and vaccines.

Novavax, Inc.

Representative: Aaron W. Pederson Carlson, Caspers, Vandenburgh & Lindquist, P.A., 225 South Sixth St., Suite 4200, Minneapolis MN 55402, UNITED STATES OF AMERICA